- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x WNH: {(2R)-1-[(4M)-4-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-6-(trifluoromethyl)pyrimidin-2-yl]azetidin-2-yl}methanol(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 2 residues within 4Å:- Chain A: G.83, H.84
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:H.84
- Water bridges: A:V.85
- Salt bridges: A:H.84
SO4.3: 3 residues within 4Å:- Chain A: K.210, K.214, W.242
2 PLIP interactions:2 interactions with chain A- Salt bridges: A:K.210, A:K.214
SO4.4: 6 residues within 4Å:- Chain A: R.125, T.270, G.272, A.273, G.274, D.275
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:G.272, A:G.272, A:G.274, A:D.275
- Salt bridges: A:R.125
SO4.7: 6 residues within 4Å:- Chain A: R.48
- Chain B: L.28, H.130, R.158, K.191, R.193
8 PLIP interactions:1 interactions with chain A, 7 interactions with chain B- Salt bridges: A:R.48, B:H.130, B:R.158, B:K.191, B:R.193
- Water bridges: B:K.191, B:K.191, B:R.193
SO4.8: 2 residues within 4Å:- Chain B: R.296, Q.300
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:Q.300, B:Q.300
- Salt bridges: B:R.296
SO4.9: 3 residues within 4Å:- Chain B: K.210, K.214, W.242
3 PLIP interactions:3 interactions with chain B- Water bridges: B:W.242
- Salt bridges: B:K.210, B:K.214
SO4.10: 5 residues within 4Å:- Chain B: R.95, R.96, G.310, F.311
- Ligands: GOL.12
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:F.311
- Water bridges: B:R.95, B:R.95, B:R.95, B:R.96
- Salt bridges: B:R.95, B:R.96
SO4.11: 4 residues within 4Å:- Chain A: W.54
- Chain B: G.83, H.84, V.85
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:H.84, B:V.85
- Water bridges: B:A.86
- 3 x GOL: GLYCEROL(Non-functional Binders)
GOL.5: 9 residues within 4Å:- Chain A: V.30, D.32, G.57, G.58, N.59, N.62, S.114, I.127, L.271
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:G.58, A:N.62, A:S.114, A:S.114
- Water bridges: A:D.32, A:D.32, A:N.59, A:N.59
GOL.12: 7 residues within 4Å:- Chain B: Q.55, R.56, G.57, N.62, G.310, F.311
- Ligands: SO4.10
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:R.56, B:N.62
- Water bridges: B:Q.55, B:Q.55, B:G.58, B:D.92, B:G.310
GOL.13: 4 residues within 4Å:- Chain B: F.283, S.284, R.289, F.297
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.289
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Durham, T.B. et al., Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor. J.Med.Chem. (2023)
- Release Date
- 2023-12-06
- Peptides
- Ketohexokinase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.99 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x WNH: {(2R)-1-[(4M)-4-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]-6-(trifluoromethyl)pyrimidin-2-yl]azetidin-2-yl}methanol(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 3 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Durham, T.B. et al., Identification of LY3522348: A Highly Selective and Orally Efficacious Ketohexokinase Inhibitor. J.Med.Chem. (2023)
- Release Date
- 2023-12-06
- Peptides
- Ketohexokinase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B